Spots Global Cancer Trial Database for Thromboelastography During Surgery for Malignant Pleural Mesothelioma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Thromboelastography During Surgery for Malignant Pleural Mesothelioma
Official Title: Thromboelastography During Surgery for Malignant Pleural Mesothelioma
Study ID: NCT01912547
Interventions
Study Description
Brief Summary: Surgery for malignant pleural mesothelioma is complex and prolonged, and may involve significant blood loss with considerable blood and product transfusion. Thromboelastography (TEG) is a global assay of coagulation that uses whole blood to produce a tracing that records kinetic changes in clot formation. This study aims provide a better understanding of the coagulation profile of these patients, and will form the basis of a TEG-based transfusion algorithm for future surgeries for mesothelioma.
Detailed Description: Thromboelastography can provide more in-depth and quicker analysis of the complex coagulation processes during surgery
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
Brigham and Women's Hospital, Boston, Massachusetts, United States
Contact Details
Name: Ju-Mei Ng, MD
Affiliation: BWH
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
